165 related articles for article (PubMed ID: 2908137)
21. The effect of acute and prolonged treatment with citalopram on the action of dopamine and SKF 38393 in rat hippocampal slices.
Bijak M; Smiałowski A
Eur J Pharmacol; 1988 Apr; 149(1-2):41-7. PubMed ID: 3260868
[TBL] [Abstract][Full Text] [Related]
22. Electrophysiological verification of the presence of D1 and D2 dopamine receptors within the ventral pallidum.
Napier TC; Maslowski-Cobuzzi RJ
Synapse; 1994 Jul; 17(3):160-6. PubMed ID: 7974198
[TBL] [Abstract][Full Text] [Related]
23. Hippocampal modulation of locomotor activity induced by focal activation of postsynaptic dopamine receptors in the core of the nucleus accumbens.
Rouillon C; Abraini JH; David HN
Hippocampus; 2007; 17(11):1028-36. PubMed ID: 17604350
[TBL] [Abstract][Full Text] [Related]
24. Dopamine D1 receptor mediation of the discriminative stimulus properties of SKF 38393.
Cunningham KA; Callahan PM; Appel JB
Eur J Pharmacol; 1985 Dec; 119(1-2):121-5. PubMed ID: 2935415
[TBL] [Abstract][Full Text] [Related]
25. Effects of dopamine agonists on excitatory inputs to nucleus accumbens neurons from the amygdala: modulatory actions of cholecystokinin.
Liang RZ; Wu M; Yim CC; Mogenson GJ
Brain Res; 1991 Jul; 554(1-2):85-94. PubMed ID: 1681991
[TBL] [Abstract][Full Text] [Related]
26. Excitatory neuronal responses to dopamine in the cerebral cortex: involvement of D2 but not D1 dopamine receptors.
Bradshaw CM; Sheridan RD; Szabadi E
Br J Pharmacol; 1985 Oct; 86(2):483-90. PubMed ID: 2932196
[TBL] [Abstract][Full Text] [Related]
27. Ontogeny of nigrostriatal dopamine neuron autoreceptors: iontophoretic studies.
Wang L; Pitts DK
J Pharmacol Exp Ther; 1995 Jan; 272(1):164-76. PubMed ID: 7815330
[TBL] [Abstract][Full Text] [Related]
28. D-1 dopamine agonist administration reduces the threshold for convulsions produced by pilocarpine.
Barone P; Palma V; Parashos SA; Marin C; Chase TN; Campanella G
Boll Soc Ital Biol Sper; 1989 Apr; 65(4):337-41. PubMed ID: 2570598
[TBL] [Abstract][Full Text] [Related]
29. Excitatory and inhibitory action of dopamine on hippocampal neurons in vitro. Involvement of D2 and D1 receptors.
Smiałowski A; Bijak M
Neuroscience; 1987 Oct; 23(1):95-101. PubMed ID: 2960914
[TBL] [Abstract][Full Text] [Related]
30. Comparison of effects of D-1 and D-2 dopamine receptor agonists on neurons in the rat caudate putamen: an electrophysiological study.
Hu XT; Wang RY
J Neurosci; 1988 Nov; 8(11):4340-8. PubMed ID: 2972814
[TBL] [Abstract][Full Text] [Related]
31. Hippocampal signal transmission to the pedunculopontine nucleus and its regulation by dopamine D2 receptors in the nucleus accumbens: an electrophysiological and behavioural study.
Yang CR; Mogenson GJ
Neuroscience; 1987 Dec; 23(3):1041-55. PubMed ID: 2963972
[TBL] [Abstract][Full Text] [Related]
32. Dopaminergic modulation of hippocampal noradrenaline release. Evidence for alpha 2-antagonistic effects of some dopamine receptor agonists and antagonists.
Jackisch R; Moll S; Feuerstein TJ; Hertting G
Naunyn Schmiedebergs Arch Pharmacol; 1985 Aug; 330(2):105-13. PubMed ID: 2995843
[TBL] [Abstract][Full Text] [Related]
33. D2 dopamine receptor-mediated mechanisms in the medial preoptic-anterior hypothalamus regulate effective defense behavior in the cat.
Sweidan S; Edinger H; Siegel A
Brain Res; 1991 May; 549(1):127-37. PubMed ID: 1680019
[TBL] [Abstract][Full Text] [Related]
34. Hypothermia in mice: D2 dopamine receptor mediation and absence of spare receptors.
Meller E; Hizami R; Kreuter L
Pharmacol Biochem Behav; 1989 Jan; 32(1):141-5. PubMed ID: 2567521
[TBL] [Abstract][Full Text] [Related]
35. D1 dopamine receptor activation required for postsynaptic expression of D2 agonist effects.
Walters JR; Bergstrom DA; Carlson JH; Chase TN; Braun AR
Science; 1987 May; 236(4802):719-22. PubMed ID: 2953072
[TBL] [Abstract][Full Text] [Related]
36. Cholecystokinin octapeptide potentiates the inhibitory response mediated by D2 dopamine receptors in slices of the ventral tegmental area of the brain in the rat.
Stittsworth JD; Mueller AL
Neuropharmacology; 1990 Feb; 29(2):119-27. PubMed ID: 2184375
[TBL] [Abstract][Full Text] [Related]
37. Effects of four dopamine agonists on l-tetrahydropalmatine-induced analgesia and electroacupuncture analgesia in rabbits.
Wu G; Jiang JW; Wu GC; Cao XD
Zhongguo Yao Li Xue Bao; 1990 May; 11(3):196-200. PubMed ID: 1982393
[TBL] [Abstract][Full Text] [Related]
38. Dopamine D1 and D2 receptor agonists induce opposite changes in the firing rate of ventral pallidal neurons.
Maslowski RJ; Napier TC
Eur J Pharmacol; 1991 Jul; 200(1):103-12. PubMed ID: 1685119
[TBL] [Abstract][Full Text] [Related]
39. Specific D1 and D2 dopamine agonists have synergistic effects in the 6-hydroxydopamine circling model in the rat.
Rouillard C; Bédard PJ
Neuropharmacology; 1988 Dec; 27(12):1257-64. PubMed ID: 2907616
[TBL] [Abstract][Full Text] [Related]
40. Functional supersensitivity of the hippocampal dopaminergic system after prolonged treatment with haloperidol.
Bijak M; Smiałowski A
Pharmacol Biochem Behav; 1989 Jan; 32(1):95-9. PubMed ID: 2567526
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
